2025
SJR Q1
JCR Q1 · 4,1
109 eşleşen makale
SCIE
Dergi ayrıntısı
Journal of Antimicrobial Chemotherapy
- Yayıncı
- Oxford University Press
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
0305745314602091
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 1,258
- Quartile Q1
- H-Index 236
- Atıf/yayın 3,68
- Doküman (3y) 1.356
- Atıf (3y) 4.972
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 4,1
- 5Y JIF 4,4
- JCI 0,99
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Infectious Diseases Q1
- Microbiology (medical) Q1
- Pharmacology Q1
- Pharmacology (medical) Q1
Alanlar
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Infectious Diseases | Microbiology | Pharmacology & Pharmacy
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,258 | 4,1 | 4,4 | 0,99 | Q1 | 236 |
| 2024 | Q1 | Q2 | 1,209 | 3,6 | 4,1 | 1,05 | Q1 | 229 |
| 2023 | Q1 | Q1 | 1,271 | 3,9 | 4,6 | 1,11 | Q1 | 229 |
| 2022 | Q1 | Q1 | 1,382 | 5,2 | 5,4 | 1,2 | Q1 | 229 |
| 2021 | Q1 | Q1 | 1,495 | 5,8 | 6,1 | 1,32 | Q1 | 229 |
| 2020 | Q1 | Q1 | 2,124 | 5,8 | 5,9 | 1,51 | Q1 | 229 |
| 2019 | Q1 | Q1 | 2,23 | 5,4 | 5,2 | 1,6 | Q1 | 229 |
| 2018 | — | Q1 | — | 5,1 | 5,1 | 1,63 | Q1 | — |
| 2017 | Q1 | Q1 | 2,419 | 5,2 | 5,2 | 1,66 | Q1 | 229 |
| 2016 | Q1 | Q1 | 2,283 | 5,1 | 5,2 | — | — | 229 |
| 2015 | Q1 | Q1 | 2,259 | 4,9 | 5,1 | — | — | 229 |
| 2014 | Q1 | Q1 | 2,298 | 5,3 | 5 | — | — | 229 |
| 2013 | Q1 | Q1 | 2,479 | 5,4 | 4,9 | — | — | 229 |
| 2012 | Q1 | Q1 | 2,283 | 5,3 | 4,7 | — | — | 229 |
| 2011 | Q1 | Q1 | 2,341 | 5,1 | 4,8 | — | — | 229 |
| 2010 | Q1 | Q1 | 2,161 | 4,7 | 4,5 | — | — | 229 |
| 2009 | — | Q1 | — | 4,4 | 4,3 | — | — | — |
| 2008 | — | Q1 | — | 4,3 | 4,2 | — | — | — |
| 2007 | — | Q1 | — | 4 | 3,7 | — | — | — |
| 2006 | — | Q1 | — | 3,9 | — | — | — | — |
| 2005 | — | Q1 | — | 3,9 | — | — | — | — |
| 2004 | — | Q1 | — | 3,6 | — | — | — | — |
| 2003 | — | Q1 | — | 3,1 | — | — | — | — |
| 2002 | — | Q1 | — | 3,3 | — | — | — | — |
| 2001 | — | Q1 | — | 3,5 | — | — | — | — |
| 2000 | — | Q1 | — | 3 | — | — | — | — |
| 1999 | — | Q1 | — | 3,3 | — | — | — | — |
| 1998 | — | Q1 | — | 2,6 | — | — | — | — |
| 1997 | — | Q1 | — | 2,3 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 34/141 |
| 2025 | MICROBIOLOGY | SCIE | Q2 | Q2 | 64/167 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 106/356 |
| 2024 | INFECTIOUS DISEASES | SCIE | Q2 | Q1 | 36/137 |
| 2024 | MICROBIOLOGY | SCIE | Q2 | Q1 | 64/163 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 103/352 |
| 2023 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 32/132 |
| 2023 | MICROBIOLOGY | SCIE | Q2 | Q1 | 57/161 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 85/354 |
| 2022 | INFECTIOUS DISEASES | SCIE | Q2 | Q1 | 29/96 |
| 2022 | MICROBIOLOGY | SCIE | Q2 | Q1 | 38/135 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 55/278 |
| 2021 | INFECTIOUS DISEASES | SCIE | Q2 | Q1 | 32/95 |
| 2021 | MICROBIOLOGY | SCIE | Q2 | Q1 | 39/137 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 54/279 |
| 2020 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 14/93 |
| 2020 | MICROBIOLOGY | SCIE | Q1 | Q1 | 26/136 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 43/276 |
| 2019 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 10/92 |
| 2019 | MICROBIOLOGY | SCIE | Q1 | Q1 | 24/136 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 22/271 |
| 2018 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 8/89 |
| 2018 | MICROBIOLOGY | SCIE | Q1 | Q1 | 22/133 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 22/267 |
| 2017 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 8/88 |
| 2017 | MICROBIOLOGY | SCIE | Q1 | Q1 | 19/126 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 19/261 |
| 2016 | INFECTIOUS DISEASES | SCIE | Q1 | — | 9/84 |
| 2016 | MICROBIOLOGY | SCIE | Q1 | — | 20/125 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 23/257 |
| 2015 | INFECTIOUS DISEASES | SCIE | Q1 | — | 9/83 |
| 2015 | MICROBIOLOGY | SCIE | Q1 | — | 19/123 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 20/255 |
| 2014 | INFECTIOUS DISEASES | SCIE | Q1 | — | 8/78 |
| 2014 | MICROBIOLOGY | SCIE | Q1 | — | 17/119 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 17/255 |
| 2013 | INFECTIOUS DISEASES | SCIE | Q1 | — | 6/72 |
| 2013 | MICROBIOLOGY | SCIE | Q1 | — | 17/119 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 17/256 |
| 2012 | INFECTIOUS DISEASES | SCIE | Q1 | — | 7/70 |
| 2012 | MICROBIOLOGY | SCIE | Q1 | — | 16/116 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 18/261 |
| 2011 | INFECTIOUS DISEASES | SCIE | Q1 | — | 7/70 |
| 2011 | MICROBIOLOGY | SCIE | Q1 | — | 18/114 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 20/261 |
| 2010 | INFECTIOUS DISEASES | SCIE | Q1 | — | 9/58 |
| 2010 | MICROBIOLOGY | SCIE | Q1 | — | 19/107 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 27/252 |
| 2009 | INFECTIOUS DISEASES | SCIE | Q1 | — | 7/57 |
| 2009 | MICROBIOLOGY | SCIE | Q1 | — | 17/95 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 32/237 |
| 2008 | INFECTIOUS DISEASES | SCIE | Q1 | — | 8/51 |
| 2008 | MICROBIOLOGY | SCIE | Q1 | — | 17/91 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 31/219 |
| 2007 | INFECTIOUS DISEASES | SCIE | Q1 | — | 9/50 |
| 2007 | MICROBIOLOGY | SCIE | Q1 | — | 16/93 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 30/205 |
| 2006 | INFECTIOUS DISEASES | SCIE | Q1 | — | 11/47 |
| 2006 | MICROBIOLOGY | SCIE | Q1 | — | 17/89 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 37/199 |
| 2005 | INFECTIOUS DISEASES | SCIE | Q1 | — | 9/43 |
| 2005 | MICROBIOLOGY | SCIE | Q1 | — | 18/86 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 31/193 |
| 2004 | INFECTIOUS DISEASES | SCIE | Q1 | — | 10/41 |
| 2004 | MICROBIOLOGY | SCIE | Q1 | — | 19/84 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 34/187 |
| 2003 | INFECTIOUS DISEASES | SCIE | Q1 | — | 9/41 |
| 2003 | MICROBIOLOGY | SCIE | Q1 | — | 19/84 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 38/185 |
| 2002 | INFECTIOUS DISEASES | SCIE | Q1 | — | 8/38 |
| 2002 | MICROBIOLOGY | SCIE | Q1 | — | 17/82 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 29/188 |
| 2001 | INFECTIOUS DISEASES | SCIE | Q1 | — | 8/37 |
| 2001 | MICROBIOLOGY | SCIE | Q1 | — | 17/81 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 23/186 |
| 2000 | INFECTIOUS DISEASES | SCIE | Q2 | — | 10/36 |
| 2000 | MICROBIOLOGY | SCIE | Q1 | — | 17/83 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 27/181 |
| 1999 | INFECTIOUS DISEASES | SCIE | Q1 | — | 6/35 |
| 1999 | MICROBIOLOGY | SCIE | Q1 | — | 14/79 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 19/175 |
| 1998 | INFECTIOUS DISEASES | SCIE | Q1 | — | 9/36 |
| 1998 | MICROBIOLOGY | SCIE | Q1 | — | 18/81 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 27/178 |
| 1997 | INFECTIOUS DISEASES | SCIE | Q2 | — | 10/34 |
| 1997 | MICROBIOLOGY | SCIE | Q1 | — | 17/73 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 26/157 |